IL-32 in PAH. ( A – D ) Triple-label immunofluorescence images of

Inhibition of immunoglobulin E attenuates pulmonary hypertension

MiR-193-3p attenuates the vascular remodeling in pulmonary arterial hypertension by targeting PAK4 - Zhenhua Wu, Jie Geng, Yujuan Qi, Jian Li, Yaobang Bai, Zhigang Guo, 2020

IJMS, Free Full-Text

Ki67 reactivity associated with vascular lesions colocalized with

Targeted Interleukin‐9 delivery in pulmonary hypertension: Comparison of immunocytokine formats and effector cell study - Heiss - 2023 - European Journal of Clinical Investigation - Wiley Online Library

Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways

Steven CHO, Assistant Professor, PhD

IL-32 in PAH. ( A – D ) Triple-label immunofluorescence images of human

TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytes

Laszlo FARKAS, Associate Professor

Targeting IL-11 system as a treatment of pulmonary arterial hypertension - ScienceDirect

Midkine (MDK) and follistatin-like 3 (FSTL3) are upregulated

Carlyne COOL, Clinical Professor

Targeting IL-11 system as a treatment of pulmonary arterial hypertension - ScienceDirect